Skip to content
Search

Latest Stories

Novo Nordisk launches recycling for injection pens with community pharmacies playing key role

Novo Nordisk has launched PenCycle, a recycling initiative for pre-filled injection pens, designed to address the challenge of recycling injection pen devices.

A first-of-its-kind scheme in the UK, covering FlexPen® and FlexTouch® used to dispense insulin and other medications, will have community pharmacies playing a key role.


Users can return their devices to local participating community pharmacies or through pre-paid Royal Mail boxes or use an ‘at home’ collection pilot service for growth hormone pens.

The pens will then be returned to Denmark where the plastic will be recycled into a range of items, such as chairs and lamps, the Danish multinational pharmaceutical company said.

PenCycle return box

As part of the initiative, participating pharmacies will be provided a PenCycle Starter Pack, containing all necessary materials, including practical guidance on the initiative, patient information and materials for patients to take home and start PenCycling.

The pilot will launch initially across Greater Manchester, Leicestershire & Rutland, and Greater Glasgow and Clyde, ahead of a planned national roll-out next year.

The pilot alone aims to recycle over 150,000 pre-filled plastic injection pen devices, ensuring over two tonnes of plastic material is diverted from the UK landfill.

By the end of 2022, it aims to recycle 1.1 million pen devices.

According to the company, the project has a potential to recycle over 3 million pen devices in 2023, preventing over 56 tonnes of plastic waste.

Pinder Sahota, general manager UK, Novo Nordisk said: “As part of our Circular for Zero initiative, we were the first pharmaceutical company to run all of our production through renewable power, and now we are taking on the challenge of recycling our plastic pen devices.

"To provide convenient options to people we have focused on establishing partnerships with community pharmacies and the Royal Mail.

“Through this recycling initiative we can help to give used pens a new purpose, and play our part in preventing further waste.”

Laura Sims, head of membership for the National Pharmacy Association, said: “We’re pleased to be supporting the PenCycle collaboration, and helping our members understand the benefits of the pilot scheme and how to take part.

"Community pharmacies dispense more than a billion prescription items each year and can greatly increase sustainability through recycling.”

Expressing delight over supporting the PenCycle initiative, Kevin Birch, chief retail officer at LloydsPharmacy, said his company is "committed to becoming a sustainable business, and we understand that our customers and patients expect us to play our part. Reducing plastic waste in our healthcare settings is a key part of our approach.”

More For You

Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less
Pharmacies in Northern Ireland distribute free booklets to raise cancer awareness

Dr Anna Cullen, Public Health Registrar at the Public Health Agency and Clare Conroy, Community Pharmacist from Meigh Pharmacy in Co Down.

Photo credit: Community Pharmacy Northern Ireland

Pharmacies in Northern Ireland help raise cancer awareness

Community pharmacies across Northern Ireland are distributing a free information booklet to help raise public awareness of the signs and symptoms of cancer and promote early diagnosis.

The initiative is part of the ‘Be Cancer Aware’ campaign, which has been running in pharmacies since April and will continue through May as part of the Living Well service.

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less